KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) Other Operating Expenses (2016 - 2025)

Globus Medical's Other Operating Expenses history spans 15 years, with the latest figure at -$372.7 million for Q3 2025.

  • For Q3 2025, Other Operating Expenses fell 31.94% year-over-year to -$372.7 million; the TTM value through Dec 2025 reached -$1.1 billion, up 9.51%, while the annual FY2024 figure was -$1.2 billion, 744.68% down from the prior year.
  • Other Operating Expenses reached -$372.7 million in Q3 2025 per GMED's latest filing, up from -$384.0 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $88.8 million in Q4 2023 to a low of -$512.5 million in Q4 2022.
  • Average Other Operating Expenses over 5 years is -$134.1 million, with a median of $4.4 million recorded in 2022.
  • Peak YoY movement for Other Operating Expenses: skyrocketed 451.52% in 2023, then crashed 5609.48% in 2024.
  • A 5-year view of Other Operating Expenses shows it stood at $21.0 million in 2021, then tumbled by 2537.29% to -$512.5 million in 2022, then soared by 117.33% to $88.8 million in 2023, then tumbled by 466.85% to -$325.8 million in 2024, then decreased by 14.42% to -$372.7 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Other Operating Expenses are -$372.7 million (Q3 2025), -$384.0 million (Q2 2025), and -$297.1 million (Q1 2025).